麻醉和呼吸市场 - 预测 2025-2030

麻醉和呼吸市场规模：

麻醉和呼吸市场预计将从 2025 年的 535.14 亿美元成长到 2030 年的 713.44 亿美元，复合年增长率为 5.92%。

麻醉和呼吸设备是重要的医疗设备，它们在医疗保健服务中发挥不同但往往互补的功能。麻醉机为接受医疗手术的患者提供可控的麻醉给药，并维持稳定的麻醉流量，以减轻疼痛和感觉，从而促进外科、医疗和精神科干预。呼吸设备确保手术过程中身体获得充足的氧气，为患有气喘、慢性阻塞性肺病(COPD) 和肺癌等严重慢性肺部疾病以及损害人体自然产氧能力的疾病的患者提供必要的支持。

麻醉和呼吸器联合系统可在手术过程中提供全面的患者照护，减少疼痛并预防呼吸道併发症。这种整合方法可确保各种医疗应用中的病患安全和手术效果。

市场驱动因素

慢性病盛行率上升

主要的市场驱动力是全球慢性病发病率的上升，这带来了对麻醉和呼吸设备的强劲需求。根据美国疾病管制与预防中心的数据，美国每十个成年人中就有六人患有慢性病，每十人中就有四人患有多种慢性病。根据澳洲卫生统计数据，每五名成年人中就有一人患有多种慢性病，每两次住院治疗中就有一次与慢性病的严重程度有关。

世界卫生组织 (WHO) 指出，心血管疾病是全球首要死亡原因，占每年死亡人数的 30% 以上。空气污染加剧导致肺部疾病和肺癌发生率上升。此外，繁重的工作日程和复杂的生活方式也显着增加了心血管疾病和需要医疗干预的胃肠道疾病的发病率。

慢性病的日益流行引发了人们对预防和挽救生命的医疗保健的兴趣，透过增加对医疗保健的需求，显着扩大了麻醉和呼吸市场。

医疗基础建设发展

医疗基础设施建设和支出的不断增长，正在加速医院和医疗单位的建设，从而推动设备需求。基础设施的扩张需要安装全面的麻醉和呼吸设备，以支持医疗机构的运作能力，从而为持续的市场成长创造机会。

人口老化

人口老化加剧以及由此带来的与老龄化相关的健康问题，推动了对用于治疗肺部疾病和其他与老龄化相关疾病的呼吸设备的需求。随着医疗保健系统不断适应老龄化人口对专业呼吸支持的需求，这一人口趋势创造了长期的市场扩张前景。

技术创新

业界的技术进步透过增强设备功能、改善患者治疗效果以及扩展应用可能性，显着促进了市场成长。技术创新推动了医疗机构的更换週期和先进解决方案的采用。

区域市场分析

亚太地区成长展望

预计亚太地区麻醉和呼吸市场在预测期内将呈现强劲成长。不断增长的基础设施建设促进了最新技术的普及，并带来了价格实惠、优质的医疗服务，这些因素正在推动该地区的成长。该地区的医疗旅游活动正在兴起，尤其是在泰国、马来西亚、印度、新加坡和韩国，价格实惠的医疗服务是一大亮点。

亚太地区的医疗保健成本优势为国际患者节省了巨额医疗费用，且医疗程序和手术费用低于其他新兴市场。这种成本竞争力预计将推动亚太地区市场的持续扩张。

预计在预测期内，旨在吸引医疗旅客的优惠政府政策将扩大市场规模。政府增加医疗保健支出，改善国内外病患的基础设施，将支持医疗旅游和麻醉及呼吸市场同步成长。

本报告的主要优点

• 深刻分析：获得深入的市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场，涵盖主要地区和新兴地区。
• 竞争格局：了解主要企业所采用的策略策略，并了解正确策略的市场渗透潜力。
• 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
• 可行的建议：利用洞察力来制定策略决策，在动态环境中开闢新的业务流和收益。
• 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业来说，既有利又划算。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

分析范围

• 历史资料（2022-2024）和预测资料（2025-2030）
• 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
• 竞争对手定位、策略和市场占有率分析
• 按部门和地区（国家）分類的收益成长和预测分析
• 公司概况（策略、产品、财务资讯、主要趋势等）

目录

第一章执行摘要

第二章市场概述

• 市场概况
• 市场定义
• 分析范围
• 细分市场

第三章 经营状况

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策法规
• 策略建议

第四章 技术展望

第五章麻醉和呼吸市场（按产品）

• 介绍
• 麻醉仪器
• 麻醉一次性用品
• 呼吸装置
• 一次性呼吸设备
• 呼吸检测设备

6. 麻醉和呼吸市场（按最终用户）

• 介绍
• 医院
• 门诊手术中心（ASC）
• 居家医疗
• 诊所和诊断中心

7. 麻醉和呼吸市场（按地区）

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第八章竞争格局及分析

• 主要企业和策略分析
• 市占率分析
• 企业合併、协议、商业合作
• 竞争对手仪表板

第九章：公司简介

• Smiths Medical
• General Electric
• Teleflex Incorporated
• Getinge AB
• OSI Systems Inc
• Koninklijke Philips NV
• Invacare Corporation
• ResMed
• Masimo
• Fisher & Paykel Healthcare Limited
• Medtronic

第十章 附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要利益
• 分析方法
• 简称

图表列表

表格列表

Anesthesia and Respiratory Devices Market Size:

The anesthesia and respiratory devices market is expected to grow from USD 53.514 billion in 2025 to USD 71.344 billion in 2030, at a CAGR of 5.92%.

Anesthesia and respiratory devices represent critical medical equipment serving distinct but often complementary functions in healthcare delivery. Anesthesia devices deliver controlled anesthesia administration to patients undergoing medical procedures, maintaining steady anesthetic flow to reduce pain and sensation for smoother procedural execution across surgical, medical, and psychiatric interventions. Respiratory devices ensure adequate oxygen flow to the body during procedures and provide essential support for patients with severe chronic lung diseases including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, and other conditions compromising natural oxygen generation capacity.

The combination of anesthesia and respiratory devices enables comprehensive patient care during surgical procedures, reducing sensation while preventing respiratory complications. This integrated approach ensures patient safety and procedural efficacy across diverse medical applications.

Market Growth Drivers

Rising Chronic Disease Prevalence

The primary market driver is the escalating incidence of chronic diseases worldwide, creating robust demand for anesthesia and respiratory devices. Chronic disease prevalence has reached significant levels globally, with data from the Center for Disease Control and Prevention indicating that 6 out of 10 adults in America suffer from chronic disease, while 4 out of 10 have multiple chronic conditions. Australian health statistics reveal that 1 in 5 adults suffers from multiple chronic diseases, with 1 in every 2 hospitalizations linked to chronic disease severity.

Cardiovascular disease represents the most common chronic condition globally, with the World Health Organization identifying CVDs as the leading cause of death worldwide, accounting for more than 30% of annual global deaths. Rising air pollution levels have contributed to increased lung disease and lung cancer cases. Additionally, demanding work schedules combined with complex lifestyle factors have significantly contributed to rising CVD and gastric disease incidences requiring medical intervention.

The growing prevalence of chronic diseases necessitates increased medical attention for prevention and life-saving procedures, substantially expanding the anesthesia and respiratory devices market size through heightened healthcare demand.

Healthcare Infrastructure Development

Rising healthcare infrastructure development and expenditure have accelerated hospital and healthcare unit construction, driving equipment demand. This infrastructure expansion creates sustained market growth opportunities as facilities require comprehensive anesthesia and respiratory device installations to support their operational capacity.

Aging Population Demographics

The growing aging population and associated age-related health complexities drive respiratory device demand to address lung diseases and other age-related conditions. This demographic trend creates long-term market expansion prospects as healthcare systems adapt to serve aging populations requiring specialized respiratory support.

Technological Innovation

Technological advancement within the industry contributes significantly to market growth through enhanced device capabilities, improved patient outcomes, and expanded application possibilities. Innovation drives replacement cycles and adoption of advanced solutions across healthcare facilities.

Regional Market Analysis

Asia Pacific Growth Prospects

The Asia Pacific anesthesia and respiratory device market demonstrates robust growth projections during the forecast period. Rising infrastructure development enabling modern technology adoption, coupled with affordable, quality healthcare services, drives regional segment growth. The region has experienced increased medical tourism activity, particularly in Thailand, Malaysia, India, Singapore, and South Korea, where affordable medical services represent primary attractions.

Healthcare cost advantages in the Asia Pacific region provide substantial savings for international patients, with medical procedures and surgeries offering cost reductions compared to other developed markets. This cost competitiveness positions the region for continued market expansion.

Favorable government policies designed to attract medical tourists are anticipated to increase market scope during the forecast period. Rising government healthcare expenditure to improve infrastructure for both domestic and international patients supports concurrent growth in medical tourism and anesthesia and respiratory device markets.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Anesthesia and Respiratory Devices Market Segments:

By Products

• Anaesthesia Machines
• Anesthesia Disposables
• Respiratory Equipment
• Respiratory Disposable Devices
• Respiratory Measurement Devices

By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Homecare Settings
• Clinics and Diagnostics Centers

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ANESTHESIA AND RESPIRATORY DEVICES MARKET BY PRODUCTS

• 5.1. Introduction
• 5.2. Anaesthesia Machines
• 5.3. Anesthesia Disposables
• 5.4. Respiratory Equipment
• 5.5. Respiratory Disposable Devices
• 5.6. Respiratory Measurement Devices

6. ANESTHESIA AND RESPIRATORY DEVICES MARKET BY END-USER

• 6.1. Introduction
• 6.2. Hospitals
• 6.3. Ambulatory Surgical Centers (ASCs)
• 6.4. Homecare Settings
• 6.5. Clinics and Diagnostics Centers

7. ANESTHESIA AND RESPIRATORY DEVICES MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. United Kingdom
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. India
  • 7.6.3. Japan
  • 7.6.4. South Korea
  • 7.6.5. Indonesia
  • 7.6.6. Thailand
  • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. Smiths Medical
• 9.2. General Electric
• 9.3. Teleflex Incorporated
• 9.4. Getinge AB
• 9.5. OSI Systems Inc
• 9.6. Koninklijke Philips N.V.
• 9.7. Invacare Corporation
• 9.8. ResMed
• 9.9. Masimo
• 9.10. Fisher & Paykel Healthcare Limited
• 9.11. Medtronic

10. APPENDIX

• 10.1. Currency
• 10.2. Assumptions
• 10.3. Base and Forecast Years Timeline
• 10.4. Key benefits for the stakeholders
• 10.5. Research Methodology
• 10.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES